Hirpara Ankit, Koshak Christina, Marty Eric, Gallus Christopher, Kleck Christopher
School of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.
Department of Orthopedic Surgery, Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.
Int J Spine Surg. 2024 Sep 12;18(4):389-399. doi: 10.14444/8621.
Interbody devices in anterior lumbar interbody fusion (ALIF) are currently a focus of innovation due to their potential to improve clinical outcomes. The purpose of the present study was to analyze complications and changes in spinopelvic parameters after ALIF with the novel Medacta MectaLIF interbody fusion device.
Patients aged 18 to 80 years who underwent multilevel ALIF using this novel implant were identified. Demographic and surgical data were collected. Patients were divided into short- and long-fusion cohorts. A comparison of outcomes between the short- and long-fusion groups was performed using the Student test for continuous variables and Fisher's exact test and the χ test for categorical variables. Analysis of the pre- vs postoperative radiographic data for the entire cohort was performed using the 2-tailed Student test.
One hundred and eight patients met the inclusion criteria. No significant postoperative change was observed in L1-4 lumbar lordosis (LL). L1-S1 LL increased to a mean of 55.1 ± 12.8 (a mean change of 10.7 ± 14.5), and L4-S1 LL increased to a mean of 38.4 ± 8.7 (a mean increase of 7.5 ± 8.2), with pelvic incidence LL mismatch changing from 8.9 ± 15.1 to 1.1 ± 13.5 ( = 102). Related changes in sacral slope and pelvic tilt were also observed (33.0 ± 11.0 to 37.6 ± 10.9 and 19.6 ± 9.5 to 18.2 ± 9.1 [ = 103], respectively). Five patients (4.6%) experienced implant subsidence, 1 (0.9%) had implant migration, and 6 (5.6%) experienced a nonunion. There was no difference in the rates of complications associated with the novel implant in the short- and long-fusion cohorts.
This novel implant achieves correction of spinopelvic parameters with minimal complications. The ability to modify the implant intraoperatively based on the patient's anatomy can help achieve maximal contact area and therefore help reduce the risk of subsidence.
This modular implant can achieve correction of spinopelvic parameters with minimal medical and surgical complications.
腰椎前路椎间融合术(ALIF)中的椎间融合器因其改善临床疗效的潜力,目前成为创新的焦点。本研究的目的是分析使用新型Medacta MectaLIF椎间融合器进行ALIF术后的并发症及脊柱骨盆参数的变化。
纳入年龄在18至80岁之间、使用该新型植入物接受多节段ALIF手术的患者。收集人口统计学和手术数据。患者被分为短节段融合组和长节段融合组。对短节段融合组和长节段融合组的结果进行比较,连续变量采用Student检验,分类变量采用Fisher精确检验和χ检验。对整个队列术前和术后的影像学数据进行分析,采用双侧Student检验。
108例患者符合纳入标准。L1-4腰椎前凸(LL)术后无显著变化。L1-S1 LL增加至平均55.1±12.8(平均变化10.7±14.5),L4-S1 LL增加至平均38.4±8.7(平均增加7.5±8.2),骨盆入射角与LL不匹配从8.9±15.1变为1.1±13.5(P = 102)。还观察到骶骨斜率和骨盆倾斜的相关变化(分别从33.0±11.0变为37.6±10.9和从19.6±9.5变为18.2±9.1 [P = 103])。5例患者(4.6%)出现植入物下沉,1例(0.9%)出现植入物移位,6例(5.6%)出现骨不连。短节段融合组和长节段融合组与新型植入物相关的并发症发生率无差异。
这种新型植入物能以最小的并发症实现脊柱骨盆参数的矫正。术中根据患者解剖结构调整植入物的能力有助于实现最大接触面积,从而有助于降低下沉风险。
这种模块化植入物能以最小的医疗和手术并发症实现脊柱骨盆参数的矫正。